CA1 participates in ischemic-induced cardiac fibroblast development, hyperglycemia-induced endothelial cell death, cell proliferation, proinflammatory cytokine production, and vascular permeability alterations, which can be suppressed by a CA1 inhibitor [9, 26]. The gene discussed is CA1; the disease is Hyperglycemia.